Home > Research > Publications & Outputs > Olanzapine increases neural chemorepulsant-drax...

Links

Text available via DOI:

View graph of relations

Olanzapine increases neural chemorepulsant-draxin expression in the adult rat hippocampus

Research output: Contribution to journalJournal articlepeer-review

Published
  • A. Pałasz
  • A. Suszka-Świtek
  • J. Francikowski
  • M. Krzystanek
  • K. Bogus
  • J. Skałbania
  • J.J. Worthington
  • I. Mrzyk
Close
Article number298
<mark>Journal publication date</mark>27/03/2021
<mark>Journal</mark>Pharmaceuticals
Issue number4
Volume14
Number of pages8
Publication StatusPublished
<mark>Original language</mark>English

Abstract

Draxin belongs to the family of inhibitory axon-guiding factors that regulate neuronal migration and axonal spreading in the developing brain. This glycoprotein has recently been considered to play an important role both in hippocampal differentiation and adult neurogenesis in the dentate gyrus. Given that it has been reported that antipsychotic drugs may affect neurite growth and neurogenesis, we have therefore investigated whether chronic treatment with olanzapine modulates draxin immunoreactivity in the adult rat hippocampus. After analysis of local fluorescence intensity, we found a significant increase of draxin immunoexpression both in the subgranular zone (SGZ) and granular zone of the rat hippocampus following long-term olanzapine administration. This study reveals, for the first time, the modulatory effect of the atypical antipsychotic medication olanzapine on expression of the novel chemorepulsive protein draxin in the context of adult neurogenesis regulation. Moreover, this is the first report dealing with pharmacological aspects of draxin signaling. An elevated draxin expression may indirectly support a recently formulated hypothesis that olanzapine may drive adult neurogenesis via paracrine draxin-related signaling. This action of draxin is a new element in the neurogenesis mechanism that may be part of the action of second-generation antipsychotics in the treatment of schizophrenia, indicating more detailed molecular studies are urgently required to fully investigate these potential novel mechanisms of neurogenesis.